XML 41 R21.htm IDEA: XBRL DOCUMENT
v3.26.1

Financial instruments | 12 Months Ended
--- | ---
Dec. 31, 2025
Notes and other explanatory information [abstract] |
Financial instruments |
13 | Financial instruments
Accounting policy Normal purchases and sales of financial assets are recognized on the trade date – the date on which the Company commits to purchase or sell the asset. Financial assets are initially recognized at fair value plus transaction costs for all financial assets not carried at fair value through profit or loss. Financial assets carried at fair value through profit or loss, if any, are initially recognized at fair value, and transaction costs are expensed in the income statement. Financial assets are derecognized when the rights to receive cash flows from the investments have expired or the Company has transferred substantially all the risks and rewards of ownership. Financial assets at fair value through profit or loss and at fair value through other comprehensive income are subsequently carried at fair value. Financial assets at amortized costs are subsequently measured using the effective interest rate method. Equity instruments may be irrevocably elected on their initial recognition for their fair value changes to be presented in other comprehensive income instead of in the income statement. Since the objective of the Company’s equity instruments is to buy more participation in a project and not sell the investment, they have been classified as fair value through other comprehensive income. Then, the Company classifies its financial assets and liabilities under the following categories: amortized cost, fair value through profit or loss and fair value through other comprehensive income.
(i) | Amortized cost
Financial assets measured at amortized cost are assets held within a business model whose objective is to hold financial assets to collect contractual cash flows and for which the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest (“SPPI”) on the principal amount outstanding. Financial liabilities are measured at amortized cost, except for financial liabilities at fair value through profit or loss such as derivatives and some specific loans and financings.
(ii) | Fair value through profit or loss
Financial assets measured at fair value through profit or loss are assets which an entity manages with the objective of realizing cash flows through the sale of such assets and financial assets that do not give rise to cash flows that are SPPI on the principal amount outstanding. Financial liabilities measured at fair value through profit or loss are liabilities which are not measured at amortized cost, such as derivatives and loans and financings where the fair value option is adopted to eliminate an accounting mismatch that would arise if amortized cost were used. For these loans and financings, the fair value variation related to the Company’s own credit risk is recorded in the OCI.
(iii) | Fair value through other comprehensive income
Financial assets measured at fair value through other comprehensive income are held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets and for which the contractual terms of the financial asset give rise on specified dates to cash flows that are SPPI on the principal amount outstanding. Investments in equity instruments are measured at fair value through other comprehensive income as mentioned before.
(a) | Breakdown by category
The Company’s financial assets and liabilities are classified as follows:
Schedule of financial instruments breakdown by category |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  | 2025
| Note |  | Amortized cost |  | Fair value through profit or loss |  | Fair value through Other comprehensive income |  | Total
Assets per balance sheet |  |  |  |  |  |  |  |  |
Cash and cash equivalents | 15 (a) |  | 515,871 |  | - |  | - |  | 515,871
Financial investments |  |  | 5,687 |  | - |  | - |  | 5,687
Other financial instruments | 16 (a) |  | - |  | 36,767 |  | - |  | 36,767
Trade accounts receivables (iii) | 17 (a) |  | 35,973 |  | 192,615 |  | - |  | 228,588
Investments in equity instruments | 14 (c) |  | - |  | - |  | 5,219 |  | 5,219
|  |  | 557,531 |  | 229,382 |  | 5,219 |  | 792,132
Liabilities per balance sheet |  |  |  |  |  |  |  |  |
Loans and financings | 24 (a) |  | 1,614,386 |  | 91,598 |  | - |  | 1,705,984
Lease liabilities | 23 (b) |  | 121,134 |  | - |  | - |  | 121,134
Other financial instruments | 16 (a) |  | - |  | 103,893 |  | - |  | 103,893
Trade payables | 25 (a) |  | 500,025 |  | - |  | - |  | 500,025
Confirming payables | 26 (a) |  | 415,388 |  | - |  | - |  | 415,388
Dividends payable |  |  | 26,918 |  | - |  | - |  | 26,918
Use of public assets (ii) |  |  | 18,808 |  | - |  | - |  | 18,808
Related parties (ii) | 20 (a) |  | 4,695 |  | - |  | - |  | 4,695
|  |  | 2,701,354 |  | 195,491 |  | - |  | 2,896,845
|  |  |  |  |  |  |  |  | 2024
| Note |  | Amortized cost |  | Fair value through profit or loss |  | Fair value through Other comprehensive income |  | Total
Assets per balance sheet |  |  |  |  |  |  |  |  |
Cash and cash equivalents | 15 (a) |  | 620,537 |  | - |  | - |  | 620,537
Financial investments |  |  | 19,693 |  | - |  | - |  | 19,693
Other financial instruments | 16 (a) |  | - |  | 5,282 |  | - |  | 5,282
Trade accounts receivables (iii) | 17 (a) |  | 39,008 |  | 101,785 |  | - |  | 140,793
Investments in equity instruments | 14 (c) |  | - |  | - |  | 5,093 |  | 5,093
Related parties (i) | 20 (a) |  | 1,546 |  | - |  | - |  | 1,546
|  |  | 680,784 |  | 107,067 |  | 5,093 |  | 792,944
Liabilities per balance sheet |  |  |  |  |  |  |  |  |
Loans and financings | 24 (a) |  | 1,670,313 |  | 92,320 |  | - |  | 1,762,633
Lease liabilities | 23 (b) |  | 95,899 |  | - |  | - |  | 95,899
Other financial instruments | 16 (a) |  | - |  | 37,134 |  | - |  | 37,134
Trade payables | 25 (a) |  | 443,288 |  | - |  | - |  | 443,288
Confirming payables | 26 (a) |  | 268,175 |  | - |  | - |  | 268,175
Dividends payable |  |  | 3,707 |  | - |  | - |  | 3,707
Use of public assets (ii) |  |  | 18,047 |  | - |  | - |  | 18,047
Related parties (ii) | 20 (a) |  | 4,085 |  | - |  | - |  | 4,085
|  |  | 2,503,514 |  | 129,454 |  | - |  | 2,632,968
(i) Classified as “Other assets” in the consolidated balance sheet. (ii) Classified as “Other liabilities” in the consolidated balance sheet. (iii) Fair value through profit or loss amounts, relates mainly to amounts included in a forfaiting program and sales that are subsequently adjusted to changes in LME prices.

X
- Definition The entire disclosure for financial instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Section Scope -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_NotesAndOtherExplanatoryInformationAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration